Literature DB >> 20726270

[Study on the compliance and economic cost of rabies vaccination].

Chuan-lin Wang1, Xiao-wei Zhang, Yong-xin Yu.   

Abstract

OBJECTIVE: To learn the compliance status regarding completing full rabies vaccination schedule, and to analyse the economic cost.
METHODS: Interviewing patients who visited doctor at Emergency Department, the People's Hospital, Beijing University from June 2007 to January 2009 on vaccination compliance of Essen regimens. The economic cost of Essen regimen and Zagreb regimen were estimated using average vaccination cost, average release amount by National Institue for Control of Pharmaceutical and Biological Products.
RESULTS: In total, 3440 patients were interviewed. The proportion completing full vaccine schedule was 33.3%, 77.1% and 78.0% for exposure category I, II and III respectively. The compliance was high for first 3 doses, it reduced significantly after the third dose. The individual medical costs was 694 RMB for Essen regimen, and 482.2 RMB for Zagreb regimen. The estimated annual medical costs was 9.709 billion RMB for Essen regimen, and 6.746 billion RMB for Zagreb regimen nationaly.
CONCLUSIONS: The Zagreb regimen should be recommended in order to simplify the vaccine administration, to increase compliance and to reduce rabies vaccination cost.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20726270

Source DB:  PubMed          Journal:  Zhongguo Yi Miao He Mian Yi        ISSN: 1006-916X


  10 in total

1.  Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.

Authors:  Jing Wang; FengJi Luo; ZiJian Feng; Li Li; YunHua Bai; Xing Ai; JianXin Ma; Zheng Zhang; NianMin Shi
Journal:  Hum Vaccin Immunother       Date:  2017-01-02       Impact factor: 3.452

2.  A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.

Authors:  Jingchen Ma; Hongchang Wang; Jun Li; Likuan Chang; Yun Xie; Zhonglin Liu; Yuliang Zhao; Claudius Malerczyk; Malerczyk Claudius
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 3.  Zagreb regimen, an abbreviated intramuscular schedule for rabies vaccination.

Authors:  Jiangping Ren; Linong Yao; Jimin Sun; Zhenyu Gong
Journal:  Clin Vaccine Immunol       Date:  2014-11-12

4.  Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.

Authors:  RongCheng Li; YanPing Li; ShuQing Wen; HuiChun Wen; Yi Nong; Zhaojun Mo; Fang Xie; Michele Pellegrini
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.

Authors:  Nianmin Shi; Yibin Zhang; Huizhen Zheng; Zhenggang Zhu; Dingming Wang; Sihai Li; Yuhua Li; Liqing Yang; Junnan Zhang; Yunhua Bai; Qiang Lu; Zheng Zhang; Fengji Luo; Chun Yu; Li Li
Journal:  Hum Vaccin Immunother       Date:  2017-01-25       Impact factor: 3.452

6.  Making rabies prophylaxis more economical: immunogenicity and safety results from a preliminary study using a 2-1 intramuscular regimen in healthy volunteers.

Authors:  Guihua Huang; Huazhang Liu; Qing Tang; Pengcheng Yu; Xinxin Shen; Yibin Zhang; Xiangyi Liu; Qing Cao; Chuanxi Fu; Beiyan Liu; Ming Wang
Journal:  Hum Vaccin Immunother       Date:  2013-09-05       Impact factor: 3.452

7.  Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial.

Authors:  Heng Shen; Zhao Wang; Beifang Yang; Kun Cai; Changjun Jiang; Ronghua Xie; Haitao Xiao; Qunhui Ren; Zhengxu Qi; Jinghui Li; Qiong Li; Jianjun Ye; Faxian Zhan
Journal:  Hum Vaccin Immunother       Date:  2020-08-12       Impact factor: 3.452

8.  Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial.

Authors:  Lei Zhang; Shichun Huang; Li Cai; Zhenggang Zhu; Jian Chen; Sha Lu; Zerong Zhu; Man Zhang; Yuan Fang; Quan Hu
Journal:  Hum Vaccin Immunother       Date:  2021-02-25       Impact factor: 3.452

9.  Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries.

Authors:  Katie Hampson; Sarah Cleaveland; Deborah Briggs
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08

10.  Exposure history, post-exposure prophylaxis use, and clinical characteristics of human rabies cases in China, 2006-2012.

Authors:  Chun Guo; Yu Li; Yang Huai; Carol Y Rao; Shengjie Lai; Di Mu; Wenwu Yin; Hongjie Yu; Shaofa Nie
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.